Apimeds Pharmaceuticals US, Inc. APUS
1.60 USD -0.14 (-8.05%)
Regular-session close
1.45 -0.15 -9.38%
After hours · Nov 20, 5:51 PM ET
1.51 Day range 1.77
1.60 52-week range 30.00
- YTD
- -90.24%
- 1 year
- -93.33%
News
globenewswire.com Apimeds Pharmaceuticals US Reports Third Quarter 2026 Results, Delivers First Operating Revenue from Technology Services Quarterly revenue of $2.89 million and operating income of $2.0 million as the company completes its transition to a technology infrastructure business
globenewswire.com $NILA Token Now Trading on PICOL, Opening Access for Eligible Users in South Korea Trading opened Monday, Nov. 16, 2026, at 8:30 a.m. ET on PICOL, a cryptocurrency trading platform focused on the South Korean market and known for its built-in automated trading bots
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 13.2% to $1.29 during Wednesday's pre-market session. The company's market cap stands at $5.4 million. The company's, Q2 earnings came…benzinga.com Apimeds’ Subsidiary MindWave Innovations Enters Into Shareholders’ And JV Agreement With Skalup Capital To Establish Insurance And Technology Business In Bermuda Under Working Brand Monaco Insurance Joint venture pairs MindWave’s blockchain infrastructure and digital-asset-backed capital, in the form of staking, with Skalup’s insurance expertise to build reinsurance capacity in one of the…
